Pharsight

Drugs that contain Perampanel

1. Fycompa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6949571 CATALYST PHARMS 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
May, 2025

(11 months from now)

US8772497 CATALYST PHARMS Method for producing 1, 2-dihydropyridine-2-one compound
Jul, 2026

(2 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-710) Jun 19, 2018
New Chemical Entity Exclusivity(NCE) Oct 22, 2017

NCE-1 date: 22 October, 2016

Market Authorisation Date: 22 October, 2012

Treatment: Treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older

Dosage: TABLET;ORAL; SUSPENSION;ORAL

How can I launch a generic of FYCOMPA before it's drug patent expiration?
More Information on Dosage

FYCOMPA family patents

Family Patents